Posted on July 23, 2012 by Sitemaster
Three papers published on line in the Journal of Urology last week have meaningful implications for greater standardization of the ways physicians need to make decisions about the appropriate identification, selection, and management of candidates for active surveillance as compared to immediate therapy. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, biopsy, expectant management, quality of care, survival | 2 Comments »
Posted on August 5, 2009 by Sitemaster
Apparently Ferring Pharmaceuticals has finally been able to get Firmagon® approved as the new trade (brand) name for degarelix (their new LHRH antagonist) here in the USA. This is the same brand name as is used in Europe. Who knows why it took so long! The media release doesn’t say.
In other news reports today we comment on studies dealing with:
- Vitamin B-6 and prostate cancer-specific survival
- Tallness and prostate cancer risk
- Quality of care indicators for prostate cancer studies … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: Degarelix, Height, quality of care, survival, tallness, vitamin B-6 | Leave a comment »
Posted on March 10, 2009 by Sitemaster
Over the past couple of years, Baker and colleagues at the University of Leicester in England have developed and “operationalized” what appears to be a relatively sophisticated survey system to rate patient and spouse/partner/caregiver experiences from initial assessment of risk for prostate cancer through post-treatment follow-up. The “New” Prostate Cancer InfoLink thinks that a similar survey might be useful in the USA and other countries! … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: patient experience, quality of care, survey, UK | Leave a comment »
Posted on August 12, 2008 by Sitemaster
Spencer et al. have evaluated the quality of cancer care received by patients diagnosed with prostate cancer based on nationally representative samples. The “New” Prostate Cancer InfoLink considers this paper to be a critically important publication, defining issues that need to be addressed by hospitals, by the American Urological Association, and by the American Society for Therapeutic Radiation Oncology. It is clear from this paper that greater consistency in quality of care is essential, even if steps are already being taken in this direction. … READ MORE …
Filed under: Management, Treatment | Tagged: cancer, early stage, prostate, quality of care | Leave a comment »